2018 BioTech Medicare Public Health 
Health Populi
MAY 20, 2021
Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. to approve Medicare’s negotiation of drug prices with pharmaceutical companies].
Advanced Medical Reviews
APRIL 17, 2019
Sharpless is a proponent of big data and previously founded two biotech companies. CMS Publishes New National Health Expenditures Data. The Center for Medicare & Medicaid Services has posted new data on projected national health expenditures for 2018-2027. percent of the country’s GDP in 2027, including a 4.8
Health Populi
JANUARY 18, 2019
Increasingly, as patients bear more first-dollar costs through high-deductible health plans, co-payments and co-insurance sharing, the patient-as-payor has become more sensitive to these prices. Chan School of Public Health with POLITICO looked into Americans’ Health and Education Priorities for the New Congress in 2019.
Expert insights. Personalized for you.
310 
Let's personalize your content